Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
SpringTide Ventures is a venture capital firm based in the United States, specializing in early-stage financing for healthcare companies. The firm has a portfolio of 8 companies and focuses on health-tech innovations. Their notable exit includes the acquisition of PathologyWatch for $150 million.
SpringTide Ventures invests in early-stage healthcare companies, particularly in the health-tech sector. Their investment strategy targets solutions in reproductive medicine, telehealth, chronic disease management, and mental health care, with check sizes typically in the pre-seed to seed-plus range.
Notable portfolio companies include Paterna Biosciences, which is pioneering solutions for male infertility, OpenLoop, providing telehealth infrastructure, and PathologyWatch, acquired by Sonic Healthcare for $150 million. Other companies include Tenovi, FlyteHealth, Nest Health, Tava Health, and Vytalize Health.
Submit your pitch through their form at springtide.com.
Yes, SpringTide Ventures often leads investment rounds in their portfolio companies, particularly in the early stages.
SpringTide Ventures is open to follow-on investments, especially for companies that demonstrate significant growth and potential in their respective markets.
The specific size of SpringTide Ventures' current fund is not publicly disclosed, but they actively manage a portfolio of 8 companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.